Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 28, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Analysis

Sinovac Biotech (SVA) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Sinovac Biotech 464.94 Mn -24.98 Bn - 8.14 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.14 Bn
Dec 31, 2025 8.54 Bn
Jun 30, 2025 11.99 Bn
Dec 31, 2024 12.34 Bn
Jun 30, 2024 12.90 Bn
Dec 31, 2023 13.61 Bn
Jun 30, 2023 13.73 Bn
Dec 31, 2022 14.03 Bn
Jun 30, 2022 15.07 Bn
Dec 31, 2021 16.76 Bn
Jun 30, 2021 12.63 Bn
Dec 31, 2020 1.90 Bn
Sep 30, 2020 658.56 Mn
Jun 30, 2020 529.37 Mn
Mar 31, 2020 433.32 Mn
Dec 31, 2019 452.30 Mn
Sep 30, 2019 410.65 Mn
Jun 30, 2019 403.83 Mn
Mar 31, 2019 381.85 Mn
Dec 31, 2018 369.78 Mn
API Access

Sinovac Biotech Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SVA&period=max&api_key=YOUR_API_KEY